Nature Reviews Cancer
@NatureRevCancer
Nature Reviews Cancer is a monthly review journal for researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research.
ID:407068486
https://www.nature.com/nrc/ 07-11-2011 15:55:51
2,4K Tweets
69,9K Followers
1,0K Following
Follow People
Cancer Cell
Cancer Cell provides a high-profile forum for showcasing advances in cancer research, with a strong emphasis on translational research.
NatureRevClinOncol
The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.
Vivek Subbiah, MD
Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Nature Medicine
Nature Medicine is a research journal devoted to publishing the latest advances in translational and clinical research for scientists and physicians.
Anirban Maitra
Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer. 🇺🇸 🇮🇳
Don´t miss this Review summarizing the different antibody-based approaches for targeting cancer cells including #CheckpointInhibitors , bispecific antibodies and #AntibodyDrugConjugates , as well as strategies that improve efficacy and reduce toxicities.
go.nature.com/3wWetGE
In case you missed Elisabeth Bik take on #ResearchIntegrity in a ‘publish or perish’ culture and on the structural changes that are needed to ensure truth in science.
go.nature.com/3yAFC2B
New Tools of the Trade: A MEGA RNA-editing tool. Victor Tiew Victor Tieu describes the development of MEGA, a platform that exploits the RNA-targeting capability of CRISPR–Cas13d and its use to improve #CART cells.
Stanley Qi Lab Mackall Lab Stanford Medicine.
go.nature.com/4dPTupO
In case you missed it: In this Tools of the Trade article, Daniel Kirschenbaum Daniel Kirschenbaum describes the development of Zman-seq and its utility for capturing dynamic changes in cellular state within single-cell RNA sequencing data.
IdoAmitLab
go.nature.com/3WOH0II
New Research Highlight: Right ON target: a new RAS-GTP inhibitor; Two studies published in Nature report the development and preclinical activity of RMC-7977, a multi-selective inhibitor targeting active GTP-bound RAS.
KenOliveLab @ColumbiaCancer
go.nature.com/3wR7Mph
In case you missed it: In this Review, Zhang&Co provide an overview of the molecular characteristics of #PaediatricCancer and highlight how these malignancies arise from developmental aberrations resulting in paediatric-specific cancer genomes.
St. Jude Research
Honoured to have the opportunity to write this obituary with my colleague Ani Deshpande. It’s a dedication for Connie from all her admirers.
Too much of a good thing is a bad thing, even for 'greedy bad guys'...
Nature Reviews Cancer has just published a research highlight on our recent work published in Cancer Discovery.
Check out this interesting piece from Nature Portfolio:
nature.com/articles/s4156…
